rs61758732

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000489.6(ATRX):​c.3541G>C​(p.Val1181Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,205,564 control chromosomes in the GnomAD database, including 3 homozygotes. There are 519 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., 43 hem., cov: 22)
Exomes 𝑓: 0.0013 ( 3 hom. 476 hem. )

Consequence

ATRX
NM_000489.6 missense

Scores

1
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: -0.798

Publications

5 publications found
Variant links:
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
ATRX Gene-Disease associations (from GenCC):
  • alpha thalassemia-X-linked intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • ATR-X-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability-hypotonic facies syndrome, X-linked, 1
    Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006064117).
BP6
Variant X-77681715-C-G is Benign according to our data. Variant chrX-77681715-C-G is described in ClinVar as Benign. ClinVar VariationId is 133659.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00131 (146/111396) while in subpopulation NFE AF = 0.0014 (74/52942). AF 95% confidence interval is 0.00114. There are 0 homozygotes in GnomAd4. There are 43 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 43 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000489.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATRX
NM_000489.6
MANE Select
c.3541G>Cp.Val1181Leu
missense
Exon 9 of 35NP_000480.3
ATRX
NM_138270.5
c.3427G>Cp.Val1143Leu
missense
Exon 8 of 34NP_612114.2P46100-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATRX
ENST00000373344.11
TSL:1 MANE Select
c.3541G>Cp.Val1181Leu
missense
Exon 9 of 35ENSP00000362441.4P46100-1
ATRX
ENST00000395603.7
TSL:1
c.3427G>Cp.Val1143Leu
missense
Exon 8 of 34ENSP00000378967.3P46100-4
ATRX
ENST00000624166.3
TSL:1
c.3337G>Cp.Val1113Leu
missense
Exon 9 of 14ENSP00000485103.1A0A096LNL9

Frequencies

GnomAD3 genomes
AF:
0.00131
AC:
146
AN:
111339
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000228
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0108
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00140
Gnomad OTH
AF:
0.000666
GnomAD2 exomes
AF:
0.00149
AC:
266
AN:
178470
AF XY:
0.00144
show subpopulations
Gnomad AFR exome
AF:
0.000153
Gnomad AMR exome
AF:
0.000113
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00844
Gnomad NFE exome
AF:
0.00147
Gnomad OTH exome
AF:
0.00113
GnomAD4 exome
AF:
0.00129
AC:
1408
AN:
1094168
Hom.:
3
Cov.:
31
AF XY:
0.00132
AC XY:
476
AN XY:
360358
show subpopulations
African (AFR)
AF:
0.0000382
AC:
1
AN:
26146
American (AMR)
AF:
0.0000868
AC:
3
AN:
34556
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19254
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30138
South Asian (SAS)
AF:
0.000343
AC:
18
AN:
52514
European-Finnish (FIN)
AF:
0.00982
AC:
397
AN:
40411
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4113
European-Non Finnish (NFE)
AF:
0.00113
AC:
950
AN:
841088
Other (OTH)
AF:
0.000849
AC:
39
AN:
45948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
53
106
160
213
266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00131
AC:
146
AN:
111396
Hom.:
0
Cov.:
22
AF XY:
0.00128
AC XY:
43
AN XY:
33614
show subpopulations
African (AFR)
AF:
0.000227
AC:
7
AN:
30788
American (AMR)
AF:
0.00
AC:
0
AN:
10488
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3558
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2611
European-Finnish (FIN)
AF:
0.0108
AC:
64
AN:
5945
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.00140
AC:
74
AN:
52942
Other (OTH)
AF:
0.000657
AC:
1
AN:
1521
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000654
Hom.:
3
Bravo
AF:
0.000582
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00173
AC:
5
ESP6500AA
AF:
0.000522
AC:
2
ESP6500EA
AF:
0.00238
AC:
16
ExAC
AF:
0.00154
AC:
187

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
Alpha thalassemia-X-linked intellectual disability syndrome (2)
-
-
1
ATRX-related disorder (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
8.6
DANN
Benign
0.71
DEOGEN2
Benign
0.0068
T
FATHMM_MKL
Benign
0.044
N
LIST_S2
Benign
0.76
T
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.0061
T
MetaSVM
Benign
-0.61
T
PhyloP100
-0.80
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.53
N
REVEL
Benign
0.12
Sift
Uncertain
0.024
D
Sift4G
Benign
0.37
T
Polyphen
0.0070
B
Vest4
0.032
MVP
0.49
MPC
0.024
ClinPred
0.0012
T
GERP RS
-3.0
PromoterAI
-0.0084
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.0
gMVP
0.12
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61758732; hg19: chrX-76937207; COSMIC: COSV64886220; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.